Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02409355
Title	A Study of MPDL3280A Compared With Gemcitabine + Cisplatin or Carboplatin in Patients With Stage IV Squamous Non-Small Cell Lung Cancer
Recruitment	Terminated
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Hoffmann-La Roche
Indications	lung non-small cell carcinoma
Therapies	Carboplatin Cisplatin Gemcitabine Atezolizumab
Age Groups:	adult
Covered Countries	USA \| ROU \| POL \| ITA \| HUN \| GRC \| GBR \| FRA \| ESP \| DEU \| CZE